KR900012628A - 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제 - Google Patents

감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제

Info

Publication number
KR900012628A
KR900012628A KR1019900001167A KR900001167A KR900012628A KR 900012628 A KR900012628 A KR 900012628A KR 1019900001167 A KR1019900001167 A KR 1019900001167A KR 900001167 A KR900001167 A KR 900001167A KR 900012628 A KR900012628 A KR 900012628A
Authority
KR
South Korea
Prior art keywords
ovarian cancer
treatment
effective amount
intraperitoneal administration
gamma interferon
Prior art date
Application number
KR1019900001167A
Other languages
English (en)
Other versions
KR100203316B1 (ko
Inventor
모드브란델리
다니엘르란도
Original Assignee
훽스트 마리온 로우셀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378406&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR900012628(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 훽스트 마리온 로우셀 filed Critical 훽스트 마리온 로우셀
Publication of KR900012628A publication Critical patent/KR900012628A/ko
Application granted granted Critical
Publication of KR100203316B1 publication Critical patent/KR100203316B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019900001167A 1989-02-02 1990-02-01 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제 KR100203316B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR89-01346 1989-02-02
FR8901346A FR2644067B1 (fr) 1989-02-02 1989-02-02 Utilisation de certains interferons gamma pour la preparation de compositions pharmaceutiques destinees au traitement du cancer de l'ovaire par voie intraperitoneale

Publications (2)

Publication Number Publication Date
KR900012628A true KR900012628A (ko) 1990-09-01
KR100203316B1 KR100203316B1 (ko) 1999-06-15

Family

ID=9378406

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900001167A KR100203316B1 (ko) 1989-02-02 1990-02-01 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제

Country Status (12)

Country Link
EP (1) EP0381584B1 (ko)
JP (1) JPH0772137B2 (ko)
KR (1) KR100203316B1 (ko)
AT (1) ATE99954T1 (ko)
AU (1) AU632528B2 (ko)
CA (1) CA2009106A1 (ko)
DE (1) DE69005837T2 (ko)
DK (1) DK0381584T3 (ko)
FR (1) FR2644067B1 (ko)
HU (1) HU204711B (ko)
OA (1) OA09191A (ko)
ZA (1) ZA90671B (ko)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon

Also Published As

Publication number Publication date
DK0381584T3 (da) 1994-02-14
DE69005837D1 (de) 1994-02-24
JPH0772137B2 (ja) 1995-08-02
HU204711B (en) 1992-02-28
FR2644067B1 (fr) 1993-02-05
EP0381584A3 (fr) 1991-11-06
KR100203316B1 (ko) 1999-06-15
HU900202D0 (en) 1990-03-28
EP0381584A2 (fr) 1990-08-08
JPH02235818A (ja) 1990-09-18
FR2644067A1 (fr) 1990-09-14
AU4895390A (en) 1990-08-09
ZA90671B (en) 1991-04-24
OA09191A (fr) 1992-06-30
CA2009106A1 (fr) 1990-08-02
HUT54302A (en) 1991-02-28
ATE99954T1 (de) 1994-01-15
AU632528B2 (en) 1993-01-07
EP0381584B1 (fr) 1994-01-12
DE69005837T2 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
DE3880766D1 (de) Konjugate von interferon alpha mit immunglobulinen.
EP0253887A1 (en) LOW INTERFERON DOSAGE FOR INCREASING VACCINE EFFECTIVENESS.
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
ATE94763T1 (de) Medikament zur behandlung von fibrotischer stoerung und antifibrotische verbindung.
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ZA904353B (en) Use of a polypeptide having the activity of human interleukin 2 for preparing a pharmaceutical composition intended for the treatment of primary cancers of the pleura
NO863027D0 (no) Peptidpreparater med kontinuerlig avgivelse.
KR900012628A (ko) 감마 인터페론의 유효량을 함유하는 복강내 투여용 난소암 치료제
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
ZA873743B (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE92333T1 (de) Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.
DE3869789D1 (de) Behandlung von einigen leukaemien mit einer zusammensetzung von interferon-gamma und interferon-alpha.
KR927003083A (ko) 인간 인터류킨 2 활성을 갖는 폴리펩티드 기재의 항종양제 조성물
DE3777224D1 (de) Verwendung von interferon-beta und interleukin-2 in der kombinationstherapie und zusammensetzungen dazu.
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
KR920014480A (ko) 기흉 치료용 제약 조성물을 제조하기 위한 인간 인터류킨 2의 활성을 갖는 폴리펩티드의 용도
IT8847847A0 (it) Dispositivo per l'erogazione di ossigeno terapeutico composto e balsamico

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J201 Request for trial against refusal decision
S901 Examination by remand of revocation
GRNO Decision to grant (after opposition)
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120305

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20130305

Year of fee payment: 15

EXPY Expiration of term